The EMCDDA shows the encouraging progress that has been made to reduce the prevalence of infectious diseases amongst people who inject drugs, while also highlighting the need to extend the existing programs and services.
Moving forward, major challenges include ensuring that new infections are prevented from occurring and that people who are living with HCV are tested, linked to care, treated, receive appropriate follow-up, and have equitable access to care.
Chang et al. call for an end to the criminalisation of drug use and the enactment of a new reality based on solidarity and cooperation, to protect the health and restore of the rights and dignity of people who use drugs.
HRI provides tools to assess national harm reduction investment and spending on drug law enforcement in seven Asian countries and insights on the state of harm reduction financing by donors and governments, civil society and community representatives.
Bonn et al sustain that the COVID-19 pandemic should be considered an opportunity to begin addressing the harms caused by the criminalization of drug use by decriminalizing personal drug use and providing a sustainable safe supply of drugs.